|
|
|
Volumn 8, Issue 3, 1997, Pages 264-278
|
|
Ethical and legal aspects of teratogenic medications: the case of isotretinoin
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISOTRETINOIN;
KERATOLYTIC AGENT;
TERATOGENIC AGENT;
ACNE VULGARIS;
ADOLESCENT;
ADULT;
BENEFICENCE;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
GENETICS AND REPRODUCTION;
GOVERNMENT;
GOVERNMENT REGULATION;
HUMAN;
INTERPERSONAL COMMUNICATION;
LEGAL APPROACH;
LEGAL LIABILITY;
MEDICAL ETHICS;
PATERNALISM;
PERSONAL AUTONOMY;
PREGNANCY;
PREGNANT WOMAN;
PROFESSIONAL PATIENT RELATIONSHIP;
REVIEW;
RISK ASSESSMENT;
ROCHE DERMATOLOGICS;
UNITED STATES;
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
PROFESSIONAL PATIENT RELATIONSHIP;
ROCHE DERMATOLOGICS;
ACNE VULGARIS;
ADOLESCENT;
ADULT;
BENEFICENCE;
DISCLOSURE;
DRUG APPROVAL;
ETHICS, MEDICAL;
FEDERAL GOVERNMENT;
FEMALE;
GOVERNMENT REGULATION;
HUMANS;
ISOTRETINOIN;
KERATOLYTIC AGENTS;
LIABILITY, LEGAL;
PATERNALISM;
PERSONAL AUTONOMY;
PREGNANCY;
PREGNANT WOMEN;
RISK ASSESSMENT;
TERATOGENS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0031216984
PISSN: 10467890
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (4)
|
